This content is machine translated Recurrent ovarian cancer Current developments give hope for a personalized approach At the ESMO Congress in Amsterdam, a review was given of the options available to date in the treatment of recurrent ovarian cancer. Therapy depends on the particular form of…
View Post 4 min This content is machine translated Metastatic renal cell carcinoma. What are the reasons for resistance to current drugs? Practical strategies for treatment management of metastatic renal cell carcinoma (mRCC) were presented at the ESMO Congress in Amsterdam. Updates on current clinical trials and the utility of new treatment…
View Post 5 min This content is machine translated New drugs Optimal use of kinase inhibitors How can kinase inhibitors be put to good use? What are the advantages or disadvantages of a combination? How can genomic sequencing contribute to an individualized therapeutic approach with such…
View Post 7 min This content is machine translated Cardiology Highlights 2013 New practice-relevant European guidelines What news did the 2013 European Congress of Cardiology in Amsterdam bring? Discussed were not only practice-relevant guidelines, but also the current trends regarding lifestyle modifications. Furthermore, studies on the…
